Skip to main content
logo
DiaSorin S.p.A. (BIT:DIA)
Italy flag Italy · Delayed Price · Currency is EUR
82.64
+2.00 (2.48%)
Nov 6, 2026, 5:35 PM CET

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Italy Revenue
180.77M181.91M176.52M
Europe Revenue
300.02M297.81M288.15M
North America Revenue
600.02M618.56M618.94M
Rest of the World Revenue
96.60M96.78M101.81M
Revenue (Other)
385.00K--
Revenue (Total)
1.18B1.20B1.19B

EBIT by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Italy Operating Profit
106.80M89.24M104.56M
Europe Operating Profit
10.58M20.02M24.35M
North America Operating Profit
115.27M141.27M140.76M
Rest of the World Operating Profit
-18.97M-19.89M1.27M
Eliminations from Operating Profit
1.74M-2.08M-12.61M
Operating Income (Other)
-53.00K--
Operating Income (Total)
215.37M228.56M258.33M

Key Performance Indicators

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Ex-COVID Immunodiagnostics % of Revenue
68.70%66.20%
Ex-COVID Molecular Diagnostics % of Revenue
16.40%17.20%
Licensed Technologies % of Revenue
13.80%14.40%
COVID % of Revenue
1.10%2.20%